Diagnostics

Accurate Identification of BCR-ABL1 Fusion Gene Mutation: Leading a Clear Pathway for Advanced Cancer Diagnostics

Kit Introduction

Why the OncoScreen® BCR-ABL1 Detection Kit?

Single Assay, Multiple Analysis

Seamlessly multitask with our ingenious technology that detects and quantifies BCR-ABL1 and ABL1 in a single assay.

Extraordinary Detection

Ensure trustworthy results with specified targeting of b2a2/b3a3 or e1a2 and an endogenous control

Groundbreaking RT-PCR technology

Upgrade your lab's performance with advanced PCR technology that simplifies Chronic Myeloid Leukemia (CML) diagnostics

Certified Quality Assurance

Wave Goodbye to PCR inhibition and reagent integrity issues with an endogenous amplification system at your disposal.

Features

Transform your lab with the OncoScreen BCR-ABL1 Detection Kit for CML diagnoses. Our kit is a multiplex qRT-PCR assay that ensures the precise detection of mutations related to CML. Attain precise and ultrasensitive results with robust reagents streamlining DNA extraction along with a pair of validated primers and a hot-start DNA polymerase for precise BCR-ABL1 Fusion Gene detection. OncoSeries- a reliable and trustworthy CML investigation kit

Reduces reflex testing by providing quantitation of three predominant BCR/ABL1 fusion transcripts

One-step quantitative detection and does not require separate cDNA synthesis and qPCR

Magnetic bead technology for robust performance and gain high yields of genetic materials.

Benefits

Accuracy
Time-Saving
Quality Controlled
Safety

Ordering Information

Manual
Catalog Number Reaction Size Enquire
1041A025 25 Enquire Now
1041A050 50 Enquire Now
1041A100 100 Enquire Now
Automated
Catalog Number Reaction Size Enquire
1041C025 25 Enquire Now
1041C050 50 Enquire Now
1041C100 100 Enquire Now

Compatible Systems

Related Kits

FAQs

Do we need to buy additional reagents for performing the assay?
The kit includes all reagents required to perform sample-to-result analysis.
Does the product require any application or website support?
No, the product does not require any website or application support.
What does the current guideline recommend?
The current guideline recommends using quantitative real-time PCR to detect and quantify BCR-ABL expression in patients with CML and ALL.
* For above information click here
APPLY FOR THIS JOB
Are you ready for this new challenge?
Thank you for choosing us!
Our team will contact you using the details provided below at the earliest opportunity.